Asia's drug dealers
The global generics industry is witnessing significant growth in M&A activity. Key drivers behind the strong trend for consolidation are the expiry of patents, an aging population and cost-constraints. Mergermarket reports on increased competition and the pressure to diversify.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts